• Clozapine N-oxide: Precision Chemogenetic Actuation in Neuro

  2026-06-10

  Clozapine N-oxide (CNO) stands at the forefront of chemogenetic research, enabling selective and reversible modulation of neuronal circuits in vivo and in vitro. This article dissects practical workflows, the latest reference breakthroughs, and expert troubleshooting to help researchers maximize the specificity and reproducibility of CNO-driven experiments.

• Ferrostatin-1 (Fer-1): Precision Control of Ferroptosis in O

  2026-06-10

  Explore how Ferrostatin-1 (Fer-1) empowers advanced ferroptosis assays and translational research in ovarian cancer models. This article uncovers new mechanistic insights and decision-making strategies for oxidative lipid damage inhibition.

• GSK343: Potent EZH2 Inhibitor for Epigenetic Cancer Research

  2026-06-09

  GSK343 is a highly selective, cell-permeable EZH2 inhibitor that enables precise inhibition of histone H3K27 trimethylation in vitro. This compound provides nanomolar potency for dissecting PRC2-mediated gene repression, supporting advanced epigenetic cancer research.

• Esflurbiprofen and Rapid Antidepressant Action via SERT-nNOS

  2026-06-09

  This study establishes esflurbiprofen as a fast-onset antidepressant by targeting the serotonin transporter (SERT)-neuronal nitric oxide synthase (nNOS) interaction within the dorsal raphe nucleus. The work introduces a robust screening strategy for SERT-nNOS interaction blockers and reveals a mechanistic cascade that accelerates serotonergic neurotransmission, offering a novel avenue for antidepressant development.

• Precision qPCR in Translational Immunopsychiatry: Next Steps

  2026-06-08

  This article offers strategic guidance for translational researchers seeking to harness high-specificity, dye-based quantitative PCR for immune profiling in neuropsychiatric disease. Drawing on mechanistic findings from adolescent major depressive disorder, it explains how the HotStart™ Universal 2X Green qPCR Master Mix empowers robust gene expression quantification, details protocol advances, and situates the technology in a rapidly evolving clinical and translational landscape.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-06-08

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent that streamlines amide bond formation for peptide synthesis and bioconjugation in aqueous systems. It is not intended for in vivo or clinical applications and should be used strictly in controlled, in vitro workflows.

• PP 3 in Src Kinase Pathway Research: Beyond Negative Control

  2026-06-07

  Explore how 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3) uniquely advances research as a research use only chemical. This article provides in-depth scientific analysis, integrating novel mechanistic insights from recent vascular studies to guide rigorous assay design.

• Dextrose (D-glucose) in Tumor Immunometabolism: Beyond the W

  2026-06-06

  Explore the pivotal role of Dextrose (D-glucose) as a metabolic substrate in advanced tumor immunometabolism research. This in-depth analysis reveals how nuanced glucose handling shapes both cellular energy production and immunosuppressive microenvironments, providing fresh insights beyond standard assay optimization.

• Magnetic Bispecific Nano-Antibodies Enable In Vivo CAR-T-Mim

  2026-06-05

  This study reports a magnetic bispecific nano-antibody platform enabling in vivo programming and tumor-directed migration of CAR-T-mimicking T cells. The approach addresses major barriers of solid tumor immunotherapy by enhancing T cell activation, infiltration, and cytotoxicity through magnetically guided targeting, offering a promising alternative to conventional ex vivo CAR-T methods.

• Triamcinolone: Technical Guidance for Glucocorticoid Researc

  2026-06-05

  Triamcinolone is a synthetic glucocorticoid agonist designed for in vitro studies of glucocorticoid signaling, inflammation, and immunosuppression pathways. This compound addresses the need for reproducible, controlled modulation of these pathways in cellular research but is not suitable for diagnostic, therapeutic, or clinical applications.

• BCECF-AM in Autophagy and Vacuolar pH: Beyond Standard pH Pr

  2026-06-04

  Explore how BCECF-AM enables advanced intracellular pH measurement, with a unique focus on autophagic vesicle degradation and vacuolar dynamics in plant cells. This article delivers new scientific insights distinct from protocol-focused guides.

• Esflurbiprofen Disrupts SERT-nNOS to Enable Rapid Antidepres

  2026-06-04

  This study identifies esflurbiprofen as a fast-onset antidepressant that operates by disrupting the interaction between the serotonin transporter (SERT) and neuronal nitric oxide synthase (nNOS) in the dorsal raphe nucleus. The findings offer proof-of-principle for targeting SERT-nNOS complexes as a strategy to accelerate antidepressant response, with implications for drug screening and mechanistic neuropharmacology.

• Trichostatin A (TSA): Boosting Epigenetic Cancer and Implant

  2026-06-03

  Trichostatin A (TSA) is redefining epigenetic research, bridging oncology and bone regeneration through potent HDAC inhibition. This article unpacks TSA’s protocol enhancements, translational opportunities, and troubleshooting best practices, spotlighting its unique role in both cancer biology and orthopedic implant integration.

• FAST Platform Enables Food-Grade Nutraceutical Nanoparticles

  2026-06-03

  The FAST platform introduces a surfactant-free, food-grade method for assembling stable, bioavailable nanoparticles from key nutraceuticals, overcoming major solubility and bioavailability barriers. This innovation accelerates clean-label supplement development and provides a scalable, regulatory-friendly route for next-generation functional foods.

• Aging Lens Epithelium’s Susceptibility to Ferroptosis Uncove

  2026-06-02

  Wei et al. provide the first direct evidence that human and mouse lens epithelial cells (LECs) become increasingly vulnerable to ferroptosis with age, implicating this cell death pathway in cataractogenesis. Their work pinpoints redox imbalance and iron dysregulation as key drivers, suggesting new avenues for mechanistic studies and therapeutic intervention.

15939 records 1/1063 page Next 12345 下5页 Last page